InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Finn Jonathan, Director. Officer active across 2 companies, notably Atossa Therapeutics, INC.. In total, 4 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €41k. Activity tracked since 10 April 2024. The latest transaction was filed on 12 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
10,000 shares0Common StockSEC:0001193125-26-224135
10,000 shares0Common StockSEC:0001193125-26-224135:0
25,000 shares@ US$1.77100.0% of flowCommon StockSEC:0000950170-24-043690:0
Ideal exit: 5 Jan 2025 (T+270)
1,206 sharesClass A Common StockSEC:0000899243-23-015559:0
4 of 4 declarations
About Finn Jonathan
Jonathan Finn is a Director at Atossa Therapeutics, Inc. As a board member, he participates in the governance of the company and strategic decision-making. His experience in the biotechnology sector allows him to provide valuable insights into growth and innovation opportunities. He plays a key role in the future direction of the company.
